Envista Holdings (NVST) Amortization of Deferred Charges (2019 - 2026)
Envista Holdings (NVST) recorded quarterly Amortization of Deferred Charges of $18.8 million in Q2 2026, up 135.67% quarter-over-quarter from -$52.7 million in Q4 2025, and little changed on a YoY basis from $18.8 million in Q2 2025.
Envista Holdings (NVST) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends
Envista Holdings' Amortization of Deferred Charges history runs 8 years deep, the most recent figure standing at $18.8 million for Q2 2026.
- In Q2 2026, Amortization of Deferred Charges changed 0.0% year-over-year to $18.8 million; the TTM figure through Apr 2026 stood at -$33.1 million (up 16.83% YoY), while the FY2025 annual figure was $4.2 million, down 14.29% from the prior year.
- Amortization of Deferred Charges was $18.8 million for Q2 2026 at Envista Holdings, up from -$52.7 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $27.9 million in Q1 2023 to a low of -$71.3 million in Q4 2023.
- Historically, Amortization of Deferred Charges has averaged -$4.2 million across 5 years, with a median of $700000.0 in 2025.
- The sharpest annual moves came in 2023 and 2025: Amortization of Deferred Charges tumbled 356.47% in 2023, then soared 1466.67% in 2025.
- A 5-year view of Amortization of Deferred Charges shows it stood at $27.8 million in 2022, then sank by 356.47% to -$71.3 million in 2023, then increased by 17.53% to -$58.8 million in 2024, then climbed by 10.37% to -$52.7 million in 2025, then jumped by 135.67% to $18.8 million in 2026.
- The last three Amortization of Deferred Charges figures came in at $18.8 million (Q2 2026), -$52.7 million (Q4 2025), and $700000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 18.80 Mn |
| Apr 3, 2026 | 18.80 Mn |
| Dec 31, 2025 | -52.70 Mn |
| Dec 31, 2025 | -52.70 Mn |
| Sep 26, 2025 | 700,000.00 |
| Sep 26, 2025 | 700,000.00 |
| Jun 27, 2025 | 100,000.00 |
| Jun 27, 2025 | 100,000.00 |
| Mar 28, 2025 | 18.80 Mn |
| Mar 28, 2025 | 18.80 Mn |
| Dec 31, 2024 | -58.80 Mn |
| Dec 31, 2024 | -58.80 Mn |
| Sep 27, 2024 | 100,000.00 |
| Sep 27, 2024 | 100,000.00 |
| Jun 28, 2024 | 100,000.00 |
| Jun 28, 2024 | 100,000.00 |
| Mar 29, 2024 | 1.20 Mn |
| Mar 29, 2024 | 1.20 Mn |
| Dec 31, 2023 | -71.30 Mn |
| Dec 31, 2023 | -71.30 Mn |